2.43
price down icon5.81%   -0.15
after-market After Hours: 2.42 -0.01 -0.41%
loading
Maravai Lifesciences Holdings Inc stock is traded at $2.43, with a volume of 5.28M. It is down -5.81% in the last 24 hours and down -40.44% over the past month. Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
See More
Previous Close:
$2.58
Open:
$2.56
24h Volume:
5.28M
Relative Volume:
1.97
Market Cap:
$344.68M
Revenue:
$288.95M
Net Income/Loss:
$-119.03M
P/E Ratio:
-2.6985
EPS:
-0.9005
Net Cash Flow:
$60.67M
1W Performance:
-6.90%
1M Performance:
-40.44%
6M Performance:
-72.51%
1Y Performance:
-69.70%
1-Day Range:
Value
$2.25
$2.67
1-Week Range:
Value
$2.25
$2.71
52-Week Range:
Value
$2.25
$11.55

Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile

Name
Name
Maravai Lifesciences Holdings Inc
Name
Phone
(858) 546-0004
Name
Address
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Name
Employee
580
Name
Twitter
Name
Next Earnings Date
2025-03-18
Name
Latest SEC Filings
Name
MRVI's Discussions on Twitter

Compare MRVI with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MRVI
Maravai Lifesciences Holdings Inc
2.43 344.68M 288.95M -119.03M 60.67M -0.9005
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
512.52 131.61B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
672.36 73.51B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
619.97 37.67B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
253.44 32.81B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
266.26 28.62B 3.81B -644.79M -669.77M -6.24

Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades

Date Action Analyst Rating Change
Feb-26-25 Downgrade Robert W. Baird Outperform → Neutral
Dec-19-24 Initiated Guggenheim Neutral
Dec-05-24 Downgrade Goldman Neutral → Sell
Nov-14-24 Initiated Wolfe Research Peer Perform
Nov-08-24 Downgrade William Blair Outperform → Mkt Perform
Aug-28-24 Initiated Wells Fargo Overweight
Aug-13-24 Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-10-24 Initiated Craig Hallum Buy
Dec-12-23 Upgrade BofA Securities Neutral → Buy
Aug-08-23 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
May-23-23 Downgrade Credit Suisse Outperform → Neutral
May-09-23 Downgrade Goldman Buy → Neutral
Jan-05-23 Downgrade UBS Buy → Neutral
Dec-14-22 Initiated Deutsche Bank Buy
Dec-07-22 Initiated RBC Capital Mkts Outperform
Nov-03-22 Downgrade BofA Securities Buy → Neutral
Aug-25-22 Initiated Credit Suisse Outperform
Aug-05-21 Resumed Credit Suisse Outperform
Dec-16-20 Initiated KeyBanc Capital Markets Overweight
Dec-15-20 Initiated BofA Securities Buy
Dec-15-20 Initiated Credit Suisse Outperform
Dec-15-20 Initiated Goldman Buy
Dec-15-20 Initiated Jefferies Buy
Dec-15-20 Initiated Robert W. Baird Outperform
Dec-15-20 Initiated Stifel Buy
Dec-15-20 Initiated William Blair Outperform
Dec-14-20 Initiated UBS Buy
View All

Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News

pulisher
07:38 AM

MRVI Investors Have Opportunity to Lead Maravai Lifesciences Holdings, Inc. Securities Fraud Lawsuit - PR Newswire

07:38 AM
pulisher
06:30 AM

Kirby McInerney LLP Reminds Maravai Lifesciences Holdings (MRVI) Investors of Securities Class Action - TradingView

06:30 AM
pulisher
05:23 AM

MRVI INVESTOR NOTICE: Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – Company AnnouncementFT.com - Financial Times

05:23 AM
pulisher
05:05 AM

Class Action Reminder for MRVI Investors: Kessler Topaz - GlobeNewswire

05:05 AM
pulisher
10:21 AM

MRVI Investors Reminded of Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire

10:21 AM
pulisher
09:40 AM

Maravai Lifesciences stock hits 52-week low at $2.33 By Investing.com - Investing.com UK

09:40 AM
pulisher
Mar 18, 2025

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Maravai LifeSciences Holdings, Inc. (MRVI) Shareholders - ACCESS Newswire

Mar 18, 2025
pulisher
Mar 18, 2025

MRVI STOCK NEWS: Maravai LifeSciences Holdings, Inc. Shareholders with Large Losses Should Contact Shareholder Rights Law Firm Robbins LLP for Information About the MRVI Securities Fraud Class Action - PR Newswire

Mar 18, 2025
pulisher
Mar 18, 2025

Maravai LifeSciences Reports Q4 EPS of $(0.18) and Revenue of $5 - GuruFocus.com

Mar 18, 2025
pulisher
Mar 18, 2025

Maravai LifeSciences Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

MARAVAI LIFESCIENCES HOLDINGS, INC. SEC 10-K Report - TradingView

Mar 18, 2025
pulisher
Mar 18, 2025

Maravai Lifesciences Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

PureCycle Lands Major $33M Backing to Scale Revolutionary Recycling Technology - StockTitan

Mar 18, 2025
pulisher
Mar 18, 2025

Maravai LifeSciences Holdings, Inc. Class Action: Levi & - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

Deadline Alert: Maravai LifeSciences Holdings, Inc. (MRVI) - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

Deadline Alert: Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.

Mar 18, 2025
pulisher
Mar 18, 2025

Maravai LifeSciences Holdings, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationMRVI - PR Newswire

Mar 18, 2025
pulisher
Mar 17, 2025

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Maravai - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Maravai Lifesciences Holdings, Inc. Investors to - Bluefield Daily Telegraph

Mar 17, 2025
pulisher
Mar 17, 2025

MRVI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

Investors who lost money on Maravai LifeSciences Holdings, - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

Investors who lost money on Maravai LifeSciences Holdings, Inc.(MRVI) should contact The Gross Law Firm about pending Class Action - GlobeNewswire Inc.

Mar 17, 2025
pulisher
Mar 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Maravai LifeSciences Holidngs, Inc. of Class Action Lawsuit and Upcoming DeadlinesMRVI - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities Class Action Lawsuit - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

Maravai LifeSciences Holdings, Inc. (MRVI) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

Maravai LifeSciences Holdings, Inc. (MRVI) Faces Securities - GlobeNewswire

Mar 17, 2025
pulisher
Mar 17, 2025

Shareholders that lost money on Maravai LifeSciences Holdings, Inc.(MRVI) should contact The Gross Law Firm about pending Class ActionMRVI - PR Newswire

Mar 17, 2025
pulisher
Mar 17, 2025

MRVI Shareholders Have Opportunity to Lead the Maravai LifeSciences Holdings, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsMRVI - The Malaysian Reserve

Mar 17, 2025
pulisher
Mar 16, 2025

MRVI Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Maravai LifeSciences Holdings, Inc. (MRVI) Investors that a Securities Fraud Class Action Lawsuit Has Been Filed - PR Newswire

Mar 16, 2025
pulisher
Mar 16, 2025

Shareholders that lost money on Maravai LifeSciences Holdings, Inc.(MRVI) should contact Levi & Korsinsky about pending Class ActionMRVI - ACCESS Newswire

Mar 16, 2025
pulisher
Mar 16, 2025

Levi & Korsinsky Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMRVI - ACCESS Newswire

Mar 16, 2025
pulisher
Mar 16, 2025

MRVI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Maravai LifeSciences Holdings, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Mar 16, 2025
pulisher
Mar 16, 2025

Maravai LifeSciences Faces Securities Class Action Lawsuit Following Financial Reporting Issues - Apna Kal

Mar 16, 2025
pulisher
Mar 16, 2025

Maravai LifeSciences Faces Securities Class Action Lawsuit Over Alleged Financial Misconduct - Apna Kal

Mar 16, 2025
pulisher
Mar 15, 2025

Kessler Topaz Meltzer & Check, LLP Reminds Maravai - GlobeNewswire

Mar 15, 2025
pulisher
Mar 15, 2025

MRVI INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire

Mar 15, 2025
pulisher
Mar 15, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Mar 15, 2025
pulisher
Mar 14, 2025

ROSEN, LEADING INVESTOR COUNSEL, Encourages Maravai - GlobeNewswire

Mar 14, 2025
pulisher
Mar 14, 2025

MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Morningstar

Mar 14, 2025
pulisher
Mar 13, 2025

Class Action Filed Against Maravai LifeSciences Holdings, - GlobeNewswire

Mar 13, 2025
pulisher
Mar 13, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Maravai LifeSciences - The Malaysian Reserve

Mar 13, 2025
pulisher
Mar 13, 2025

The Gross Law Firm Notifies Maravai LifeSciences Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMRVI - PR Newswire

Mar 13, 2025
pulisher
Mar 12, 2025

Marvai LifeSciences Holdings, Inc. Shareholders with Large Losses are Encouraged to Contact Robbins LLP for Information About Leading the Securities Fraud Class Action Lawsuit Against MRVI - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Marvai LifeSciences Holdings, Inc. Shareholders with Large Losses are Encouraged to Contact ... - Bluefield Daily Telegraph

Mar 12, 2025
pulisher
Mar 12, 2025

Marvai LifeSciences Holdings, Inc. Shareholders with Large - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

MRVI INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire

Mar 12, 2025
pulisher
Mar 12, 2025

Lowey Dannenberg Notifies Maravai LifeSciences Holdings, - GlobeNewswire

Mar 12, 2025
pulisher
Mar 12, 2025

Levi & Korsinsky Notifies Shareholders of Maravai LifeSciences Holdings, Inc. (MRVI) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

Mar 12, 2025
pulisher
Mar 12, 2025

Shareholders that lost money on Maravai LifeSciences Holdings, Inc.(MRVI) Urged to Join Class Action – Contact Levi & Korsinsky to Learn More - ACCESS Newswire

Mar 12, 2025
pulisher
Mar 12, 2025

Levi & Korsinsky Reminds Maravai LifeSciences Holdings, Inc. Inv - GuruFocus.com

Mar 12, 2025
pulisher
Mar 12, 2025

Levi & Korsinsky Reminds Maravai LifeSciences Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 5, 2025MRVI - PR Newswire

Mar 12, 2025

Maravai Lifesciences Holdings Inc Stock (MRVI) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$78.94
price up icon 2.53%
$318.85
price up icon 1.51%
$33.41
price up icon 0.00%
$20.11
price up icon 1.41%
$99.27
price up icon 0.31%
biotechnology ONC
$266.26
price up icon 1.87%
Cap:     |  Volume (24h):